Geron | GERN - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Amgen USD 25.5B 547M 2026-06
Bio Techne USD 153.28M 12.85M 2026-03
Cassava Sciences USD 40.11M 3.72M 2026-03
Cytokinetics USD 181.43M 17.76M 2026-06
Exelixis USD 361.93M 9.05M 2026-06
Genmab DKK 1.14B 38M 2026-06
Geron USD 70.33M 3.24M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Incyte USD 1.31B 177.55M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
Novartis USD 31.75B 374M 2026-06
Novavax USD 330.57M 11.89M 2026-06